Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Hugo Gass"'
Autor:
Ana Laura Pereira Suarez, Mario Alejandro Lorenzetti, Rene Gonzalez Lucano, Melina Cohen, Hugo Gass, Paula Martinez Vazquez, Pedro Gonzalez, Maria V Preciado, Paola Chabay
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e61613 (2013)
BackgroundThe etiology and the molecular mechanisms related to breast carcinogenesis remain poorly understood. Some recent reports have examined the role of Human Papillomavirus (HPV) in this disease. The purpose of this study was to determine the pr
Externí odkaz:
https://doaj.org/article/45029f47f48b4cd38b9d1f7a0cae11ea
Autor:
Mario A Lorenzetti, Elena De Matteo, Hugo Gass, Paula Martinez Vazquez, Julia Lara, Pedro Gonzalez, María Victoria Preciado, Paola A Chabay
Publikováno v:
PLoS ONE, Vol 5, Iss 10, p e13603 (2010)
INTRODUCTION: Epstein-Barr virus (EBV)-associated tumors show different expression patterns of latency genes. Since in breast carcinoma this pattern is not yet fully described, our aim was to characterize EBV latency pattern in our EBV positive breas
Externí odkaz:
https://doaj.org/article/918b260c9c334e9ca1b1ea6d6e43e141
Autor:
Andrés Elía, Leo Saldain, Silvia I. Vanzulli, Luisa A. Helguero, Caroline A. Lamb, Victoria Fabris, Gabriela Pataccini, Paula Martínez-Vazquez, Javier Burruchaga, Ines Caillet-Bois, Eunice Spengler, Gabriela Acosta Haab, Marcos Liguori, Alejandra Castets, Silvia Lovisi, María F. Abascal, Virginia Novaro, Jana Sánchez, Javier Muñoz, José M. Belizán, Martín C. Abba, Hugo Gass, Paola Rojas, Claudia Lanari
Publikováno v:
Clinical Cancer Research. 29:866-877
Purpose:Preclinical data suggest that antiprogestins inhibit the growth of luminal breast carcinomas that express higher levels of progesterone receptor isoform A (PRA) than isoform B (PRB). Thus, we designed a presurgical window of opportunity trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99b912e6687a9a29640f99d418237391
https://doi.org/10.1158/1078-0432.ccr-22-2060
https://doi.org/10.1158/1078-0432.ccr-22-2060
Autor:
Claudia Lanari, Paola Rojas, Hugo Gass, Martín C. Abba, José M. Belizán, Javier Muñoz, Jana Sánchez, Virginia Novaro, María F. Abascal, Silvia Lovisi, Alejandra Castets, Marcos Liguori, Gabriela Acosta Haab, Eunice Spengler, Ines Caillet-Bois, Javier Burruchaga, Paula Martínez-Vazquez, Gabriela Pataccini, Victoria Fabris, Caroline A. Lamb, Luisa A. Helguero, Silvia I. Vanzulli, Leo Saldain, Andrés Elía
RNA-Seq and Proteomics analysis. A and B, Dot plot of relevant enriched pathways from GSEA results (Reactome and Hallmark databases) separating responsive (A) and unresponsive tumors (B). C, Immune cell deconvolution (xcell) in the different tumors a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62d6792c68f8f402636d49008d19cd98
https://doi.org/10.1158/1078-0432.22490276
https://doi.org/10.1158/1078-0432.22490276
Autor:
Claudia Lanari, Paola Rojas, Hugo Gass, Martín C. Abba, José M. Belizán, Javier Muñoz, Jana Sánchez, Virginia Novaro, María F. Abascal, Silvia Lovisi, Alejandra Castets, Marcos Liguori, Gabriela Acosta Haab, Eunice Spengler, Ines Caillet-Bois, Javier Burruchaga, Paula Martínez-Vazquez, Gabriela Pataccini, Victoria Fabris, Caroline A. Lamb, Luisa A. Helguero, Silvia I. Vanzulli, Leo Saldain, Andrés Elía
RNA-Seq Variant calling
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81a80723a943845d57a6412590544235
https://doi.org/10.1158/1078-0432.22490249
https://doi.org/10.1158/1078-0432.22490249
Autor:
Claudia Lanari, Paola Rojas, Hugo Gass, Martín C. Abba, José M. Belizán, Javier Muñoz, Jana Sánchez, Virginia Novaro, María F. Abascal, Silvia Lovisi, Alejandra Castets, Marcos Liguori, Gabriela Acosta Haab, Eunice Spengler, Ines Caillet-Bois, Javier Burruchaga, Paula Martínez-Vazquez, Gabriela Pataccini, Victoria Fabris, Caroline A. Lamb, Luisa A. Helguero, Silvia I. Vanzulli, Leo Saldain, Andrés Elía
Purpose:Preclinical data suggest that antiprogestins inhibit the growth of luminal breast carcinomas that express higher levels of progesterone receptor isoform A (PRA) than isoform B (PRB). Thus, we designed a presurgical window of opportunity trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1efca7051031f2a880f05b2613d47d1f
https://doi.org/10.1158/1078-0432.c.6533123.v1
https://doi.org/10.1158/1078-0432.c.6533123.v1
Autor:
Claudia Lanari, Paola Rojas, Hugo Gass, Martín C. Abba, José M. Belizán, Javier Muñoz, Jana Sánchez, Virginia Novaro, María F. Abascal, Silvia Lovisi, Alejandra Castets, Marcos Liguori, Gabriela Acosta Haab, Eunice Spengler, Ines Caillet-Bois, Javier Burruchaga, Paula Martínez-Vazquez, Gabriela Pataccini, Victoria Fabris, Caroline A. Lamb, Luisa A. Helguero, Silvia I. Vanzulli, Leo Saldain, Andrés Elía
Morphological evaluation of CNBs and matched surgical samples; RNA-Seq analysis; Proteomics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5a15542d13a638249a3223b51a95718
https://doi.org/10.1158/1078-0432.22490267.v1
https://doi.org/10.1158/1078-0432.22490267.v1
Autor:
Andres Elia, Martin Abba, Hugo Gass, Caroline A Lamb, Victoria T Fabris, Paula Martinez Vazquez, Javier Burruchaga, Eunice Spengler, Ines Caillet Bois, Alejandra Castets, Silvia Lovisi, Marcos Liguori, Gabriela Pataccini, Maria Florencia Abascal, Virginia Novaro, Alfredo Molinolo, Silvia I Vanzulli, Paola Rojas, Claudia Lanari
Publikováno v:
Cancer Research. 82:P5-16
Background: Preclinical data suggests that antiprogestins inhibit the growth of luminal breast carcinomas expressing higher levels of progesterone receptor isoform A (PRA) than isoform B (PRB). Thus, we designed a pre-surgical window of opportunity t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::902429185810d79a659ab84c5c12e350
https://doi.org/10.1158/1538-7445.sabcs21-p5-16-09
https://doi.org/10.1158/1538-7445.sabcs21-p5-16-09
Autor:
Andrés, Elía, Leo, Saldain, Silvia I, Vanzulli, Luisa A, Helguero, Caroline A, Lamb, Victoria, Fabris, Gabriela, Pataccini, Paula, Martínez-Vazquez, Javier, Burruchaga, Ines, Caillet-Bois, Eunice, Spengler, Gabriela, Acosta Haab, Marcos, Liguori, Alejandra, Castets, Silvia, Lovisi, María F, Abascal, Virginia, Novaro, Jana, Sánchez, Javier, Muñoz, Jose M, Belizán, Martín C, Abba, Hugo, Gass, Paola, Rojas, Claudia, Lanari
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research.
Preclinical data suggest that antiprogestins inhibit the growth of luminal breast carcinomas that express higher levels of progesterone receptor isoform A (PRA) than isoform B (PRB). Thus, we designed a pre-surgical window of opportunity trial to det
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c272ec24b775d8c84eff5215beb3e7f3
https://pubmed.ncbi.nlm.nih.gov/36269797
https://pubmed.ncbi.nlm.nih.gov/36269797
Autor:
Silvia Vanzulli, Paola Andrea Rojas, Alejandra Castets, Gabriela Acosta Haab, Javier Burruchaga, Claudia Lanari, Ines Caillet Bois, Marcos Liguori, Silvia Lovisi, Eunice Spengler, Gabriela Pataccini, Virginia Novaro, M Florencia Abascal, Paula Martinez Vazquez, Alfredo A. Molinolo, Hugo Gass, Victoria Teresa Fabris, Caroline A. Lamb, Andres Elia
Publikováno v:
Cancer Research. 81:PS11-35
Background: Different antiprogestins have been clinically evaluated in gynecological andbreast cancers. Mifepristone (MFP), as well as onapristone and telapristone acetate, showedpartial responses in breast cancer clinical trials. Preclinical data in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a75ddf97f2c256b5c4227d20e6636fa0
https://doi.org/10.1158/1538-7445.sabcs20-ps11-35
https://doi.org/10.1158/1538-7445.sabcs20-ps11-35